Friday, October 19, 2018
Redactor's Choice
You are here: Home / Tag: United States (page 24)

Tag: United States

Lyxumia is first diabetes therapy of its class approved in Japan for use in combination with basal insulin

doc

“Lyxumia, as the first GLP-1 receptor agonist approved in Japan for use in combination with basal insulin, will be a valuable new treatment option for many of the country’s 6 million plus people living with type 2 diabetes,” said Pierre Chancel, Senior Vice-President, Global Diabetes at Sanofi. “The MHLW decision immediately enables the use of Lyxumia, which works in a way that complements basal insulin.” Although basal insulin treatment provides effective control of overall glucose excursions by primarily targeting fasting plasma glucose (F... Read More »

Sanofi expands collaboration with GDF SUEZ to reduce its global energy consumption

laboratory

Building on the success of the initial agreement signed in March 2012 for Europe and Turkey, the two groups have expanded their collaboration to now include sites in the United States, Canada, Mexico, Brazil, China and Singapore. All Sanofi’s production lines will be covered: chemicals, pharmaceuticals, vaccines, biotechnology and animal health. The initial three-year term contract is extended to five years. “Thanks to the global footprint of Sanofi and GDF Suez, this innovative partnership enables us to improve our competitiveness and achie... Read More »

Scroll To Top